STAT3 and cancer: Notably, alantolactone (28), atractylenolide I (172), imperatorin (175), ursolic acid (170, 179), and brassinin (171) have further emphasized the therapeutic potential of targeting STAT3 to prevent fat loss in cancer cachexia.